ATX-IN-3

• Target:

  PDE

• Related Pathways:

  Metabolism

• Bioactivity:

  ATX-IN-3 is an orally active autotaxin (ATX) inhibitor with an IC50 of 46 nM. It effectively ameliorates pulmonary fibrosis in mouse models by significantly reducing collagen deposition. ATX-IN-3 demonstrates excellent metabolic stability and drug-like properties, making it suitable for research on idiopathic pulmonary fibrosis (IFP) .

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C